TRCT
CNSY

Tower Research Capital (TRC)’s Cerenome CNSY Stock Holding History

Tower Research Capital (TRC)’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.54K Buy
+1,955
New +$10.7K ﹤0.01% 4065
2025
Q4 		– Sell
-141
Closed -$2.41K – 5491
2025
Q3 		$2.41K Sell
141
-101
-42% -$1.24K ﹤0.01% 4634
2025
Q2 		$2.1K Sell
242
-65
-21% -$850 ﹤0.01% 4700
2025
Q1 		$7.29K Buy
307
+116
+61% +$3.24K ﹤0.01% 3964
2024
Q4 		$5.5K Buy
191
+43
+29% +$1.38K ﹤0.01% 4279
2024
Q3 		$5.42K Sell
148
-19
-11% -$750 ﹤0.01% 4278
2024
Q2 		$6.15K Buy
167
+14
+9% +$687 ﹤0.01% 4613
2024
Q1 		$6.91K Buy
153
+130
+565% +$6.29K ﹤0.01% 4296
2023
Q4 		$1K Sell
23
-35
-60% -$1.4K ﹤0.01% 5464
2023
Q3 		$1.94K Sell
58
-131
-69% -$7.03K ﹤0.01% 5235
2023
Q2 		$9.56K Buy
189
+165
+688% +$15.4K ﹤0.01% 4256
2023
Q1 		$3K Hold
24
– – ﹤0.01% 5230
2022
Q4 		$3K Sell
24
-2
-8% -$318 ﹤0.01% 5220
2022
Q3 		$4K Sell
26
-28
-52% -$6.25K ﹤0.01% 5283
2022
Q2 		$11K Buy
54
+29
+116% +$7.24K ﹤0.01% 4386
2022
Q1 		$9K Buy
+25
New +$9.51K ﹤0.01% 4477
2021
Q4 		– Hold
0
– – – 6478
2021
Q2 		– Sell
-5
Closed -$5K – 5760
2021
Q1 		$5K Buy
5
+4
+400% +$4.05K ﹤0.01% 4687
2020
Q4 		$1K Sell
1
-2
-67% -$1.71K ﹤0.01% 5025
2020
Q3 		$3K Buy
+3
New +$2.91K ﹤0.01% 4517
2016
Q3 		– Hold
0
– -$2K – 4265
2016
Q2 		– Hold
0
– – – 3942
2016
Q1 		– Hold
0
– – – 4759
2015
Q4 		– Hold
0
– – – 4934
2015
Q3 		– Hold
0
– -$2K – 4610
2015
Q2 		– Hold
0
– – – 3777
2014
Q4 		– Hold
0
– -$25K – 4555
2014
Q3 		– Hold
0
– – – 2124
2014
Q2 		– Hold
0
– – – 3735
2014
Q1 		– Hold
0
– – – 3895

Other funds holding CNSY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Tower Research Capital (TRC)'s CNSY Position: Q2 2026 in Review

Tower Research Capital (TRC) opened a new position in Cerenome (CNSY) in Q2 2026: 1,955 shares worth $8.54K. The stake represents ﹤0.01% of the portfolio and ranks #4065 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in CNSY as recently as Q3 2025.

Tower Research Capital (TRC) first reported a position in CNSY in Q3 2020 and has held it in 19 quarters since. The position peaked at $11K in Q2 2022. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Tower Research Capital (TRC) held 1,955 shares of Cerenome worth $8.54K as of Q2 2026.
  • Cerenome was a new Tower Research Capital (TRC) position in Q2 2026.
  • Cerenome made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4065 holding.
  • Tower Research Capital (TRC) first reported a position in Cerenome in Q3 2020 and has held it in 19 quarters since.
  • Tower Research Capital (TRC)'s Cerenome position peaked at $11K in Q2 2022.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.